Philip Morris
Cardiovascular Effects of Ets Exposure: Comments on Biological Plausibility of Proposed Mechanisms
Fields
- Type
- SCRT, REPORT, SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- DRAW, DRAWING
- BIBL, BIBLIOGRAPHY
- Area
- MCALPIN,LOREEN/OFFICE
- Master ID
- 2057837080/7446
Related Documents:- 2057837085 Increased Experimental Atherosclerosis in Cholesterol-Fed Rabbits Exposed to Passive Smoke: Taking Issue with Study Design and Methods of Analysis
- 2057837087-7093 Testimony in Response to OSHA's Identification of Cardiovascular Disease As A Hazard Resulting From Exposure to Environmental Tobacco Smoke in the Workplace
- 2057837107-7108 Comments on the Notice of Proposed Rulemaking Issued by the U.S. Occupational Safety and Health Administration Addressing Indoor Air Quality in Indoor Work Environments
- 2057837109-7152 A Critical Examination of the OSHA Ets Risk Assessment
- 2057837153-7182 An Alternative Explanation for the Apparent Elevated Relative Mortality and Morbidity Risks of Spouses and Other Family Members of Smokers Associated with Exposure to Environmental Tobacco Smoke
- 2057837186-7207 Curriculum Vitae Theodor D.Sterling
- 2057837264-7278 Environmental Tobacco Smoke and Coronary Heart Syndromes: Absence of An Association
- 2057837281-7372 OSHA Posthearing Submission
- 2057837374-7377 Ischemic Heart Disease and Spousal Smoking in the National Mortality Followback Survey
- 2057837379-7386 Publication Bias in the Environmental Tobacco Smoke / Coronary Heart Disease Epidemiologic Literature
- 2057837388-7389 Sidestream Cigarette Smoke and Arteriosclerosis
- 2057837419-7445 Biological Mechanisms Accounting for the Purported Relationship Between Environmental Tobacco Smoke Exposure and Adverse Cardiovascular Effects: A Response to Dr. Glantz
- Request
- Stmn/R1-028
- Named Person
- Aronow, W.S.
- Burghuber, O.C.
- Davis, J.W.
- Doll, R.
- Gvozdjakova, A.
- Haire, W.D.
- Hladovec, J.
- Lehr, I.
- Mehrabian, M.
- Messinger, H.B.
- Moskowitz, W.P.
- Peto, R.
- Pettersson, K.
- Rosenman, R.H.
- Rossman, P.
- Rozanski, A.
- Sheps, D.S.
- Wilhelmsen, L.
- Zhu
- Burghuber, O.C.
- Document File
- 2057837078/2057837447/Cal Epa Appendix III
- Litigation
- Stmn/Produced
- Named Organization
- OSHA, Occupational Safety & Health Administration
- World Health Org Expert Comm
- Site
- R635
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- tba64e00
Document Images
I
I
I
I
I
~
I
I
I
I
cardiovascular Effects of ETS Exposure:
Comments on Biological Plausibility of Proposed Mechanisms
1
I

Table of Contents
A. Coronary Heart Disease
Al. xajor events associated with atherosclerosis
I
I
I
I
I
I
I
1
A2. The'.tiology of atherosclerosis remains unknown
B. Summary of epidemiological studies relating cardiovascular
effects with exposure to ETS
C. commeats on deficiencies and lack of biological plausibility in
the mechanisms proposed for the cardiovascular efAfects of ETS
C1. Thrombus formation and platelet activation: Does- exposure to
ETS contribute to an altered platelet function?
C2. Vascular wall injury: Is ETS exposure associated with
endothelial cell injury?
C3. Does ETS exposure alter the uptake or the composition of
lipids?
C4. Is ETS exposure associated with increased proliferation of
s.m.ooth muscie cells?
. . ....... . .........
C5. What is the biological relevance of exposure to ETS on
oxygen supply and cardiac functions?
C6. How appropriate is it to extrapolate findings from animal
studies to investigations involving human subjects?
C7. Confounding
D. An alternative explanation for the observed effects of ETS
.............
D1. Psychoactive responses to ETS
D2. Psychoactive factors and pathogenesis of atherosclerosis
B. conclusion
I

I
I
I
I
I
I
I
A. Coronary Heart Disease
Heart disease and related cardiovascular ailments are the
primary cause of death in all developed countries and in many
developing countries. Coronary heart disease (CHD), which accounts
for a quarter of the 21 million deaths each year among Americans,
is a complex clinical composite of a more fundamental vascular
pathology affecting circulation (1). The majority of these deaths
_..:.... _
are due to myocardial or cerebral infarction, severe
atherosclerosis being the principal cause, accounting for 90% of
CHD mortalities (1). CHD is known to have a substantial diagnostic
error (2). In addition, a significant percentage (36% in women and
38.7% in men) of CHD among'adults aged k65 years is subclinical
(3), suggesting that assessment of CHD-linked morbidity and
mortality, based on traditional clinical parameters, may be
imprecise (4). Unfortunately, these factors, insofar as CHD is
concerned, are rarely considered in large-scale epidemiologic
studies.
Al. Major events associated with atherosclerosis
Atherosclerosis refers to the process in which cholesterol-
laden, hemorrhagic deposits, referred to as atheromas, are formed
in the tunica intima and media of large and medium sized arteries.
Although atheromas develop in all arteries, they are more common in
areas of high'blood turbulence, such as coronary arteries and
aorta. In the case of coronary arteries, damage of endothelium
lining the arterial wall triggers a series of events, culminating
Y

I
I
I
I
I
I
I
I
I
I
I
in the attachment of cholesterol and related lipids to damaged
-
endothelial cells. Cholesterol intermingles with cells of the
lining, and develops into a plaque. With time the plaque, soft and
fibrous at first, stiffens and weakens the artery wall (5). The
arteries become brittle and more vulnerable to tears and
hemorrhages. The thickened vascular wall, in addition to becoming
prone to coronary thrombosis, also compromises the vessel lumen and
causes a decrease in blood flow. Since coronary arteries supply the
,, heart with blood, the "narrowing of the arteries° mav eventually
show itself in the form of clinical symptoms. The person may
experience angina.pectoris,-or severe chest pains, when the heart
is insufficiently oxygenated or placed under extra demands, e.g.,
rigorous physical exercise. Another clinical manifestation of
atherosclerosis is myocardial infarction which can result in fatal
destruction of heart tissues.
Fiqure l illustrates the sequence of events that result in
atheroma formation. The whole process is believed to be initiated
by some form of injury, arising from systemic and local changes in
the arterial network, to endothelial cells lining the arteries.
Subsequent to endothelium damage, atherosclerotic lesions develop
over time and are thought to be the collective end-product of three
somewhat inter-dependent events: (i) proliferation of previously
quiescent smooth muscle cells and activation of macrophages
recruited to site of damage, (ii) deposition of large amounts of
connective tissue matrix proteins, e.g., collagen, elastic fibers,
proteoglycan, around the smoQth muscle cells, and (iii) lipid
I

I
I
I
I
I
I
I
I
I
I
I
accumulation in the form of foam cells within smooth muscle cells
and macrophages, and as deposits within the extracellular matrix
surrounding these cells.
A2. The etiology of atherosclerosis remains unknown
Despite the strides that have been made in vascular biology in
recent years, including those at the molecular level, the etiology
of atherosclerosis remains uncertain. This uncertainty is reflected
in the following question:!'what is the nature or mechanism of the
primary injury of the vessel wall which appears to initiate the
process of atherogenesis?"
Based on leads provided by epidemiological investigations,
suggestions have been made of association between atherosclerotic
disease and a series of pathologies, habits of the population,
genetic, biochemical, physiological and environmental.factors, all
of which influence directly and/or indirectly the early
development, frequency, severity and prognosis of atherosclerosis.
These have come to be known as coronary risk factors (CRF). CRFs
can range from more esoteric risks such as noise, and behavior, to
more commonly accepted risks such as elevated plasma LDL
cholesterol levels, lowered HDL cholesterol levels, triglyceride
and beta/alpha lipoprotein ratio, serum clotting times, fibrinogen
concentrations, cigarette smoking, high blood pressure, obesity,
diabetes mellitus, and sedentary lifestyles (7-20). It is also
..
important to note that the classical risk factors, such as
hypercholesterolemia, hypertension, hemodynamic stresses, smoking,
which have been traditionally cited for their predisposing roles
I

leading to endothelial cell injury - both, in animal and human
,._
studies - are still unable to account for the mechanism of
atherogenesis, or predict >50% of new cases of the disease (21).
To summarize, because of the multifactorial nature of CHD, in
which magnitude and severity of disease are influenced both by
duration of exposurP and by the particular combination of the CRFs,
it is extremely unlikely that an increase in the risk of CHD may be
traced and assigned exclusively to a single CRF.
B. Summary of epidemiological studies relating
cardiovascular effects and ETS exposure
ETS is a combination of smoke emitted from the burning
cigarette and smoke exhaled by the smoker. It consists of a vapor
and a particulate phase, formed by a multifaceted kinetic process
(22). The particulate phase of ETS is created when combustion_
components are emitted into the atmosphere. These components act as
"nuclei" for condensation of vapor phase material. The final
droplets of ETS are in a dynamic state of flux which is influenced
by humidity, dissipation, and dilution (22, 23). The effects of ETS
exposure are dependent upon many factors, such as bioavailability
of particulate and vapor_phase constituents, as well as duration
and level of exposure (24).
The relationship between exposure to ETS and incidence of CHD
is a subject of controversy. Reasons for not associating between
the two include the following:
(i) ETS exposure occurring over an extended period of time
involves multiple, ill-defined modes of exposure and is subject to

t
1
I
I
I
I
I
I
I
known and unknown quantification/measurement errors (22-24). Given
that CHD is associated with many CRFs and requires years of
incubation to surface clinically, it is unlikely that a significant
,
risk is attributable to ETS exposure.
(ii) Of the numerous epidemiological studies that examine
possible associations between CHD and ETS exposure (25-34), only
three of the studies, involving exposure at home to spousal ETS,
report a statistically significant association between ETS and CHD
(26, 28, 34). In the single study to assess the health effects of
workplace ETS exposure, no statistically significant association
, .
was found (34). Since, by their very nature, epidemiologic studies
deal with masses of data, it is unclear whether sample homogeneity
can be maintained and whether the quality of the observations can
be preserved. Furthernaore, there is often confounding of effects.
Indeed, issues such as indices for ETS exposure; lifestyle factors;
,....
_ _
_.
and misclassifications, in relation to the purported effects of
ETS, have not been completely resolved.
.
_ .............. .... ...........
(iii) Although probable carcinogens such as benzo(a)pyrene
(H(a)P) and dimethylnitrosamine (DMNA) have been detected in
sidestream tobacco smoke (in some cases, in concentrations
exceeding those present in mainstream tobacco smoke (23)), they are
substantially diluted when present in ETS. In addition, with the
addition of carbon monoxide, it is not known whether and how many
of the potentially harmful chemical components present in ETS can
gain access to the cardiovascular system in concentrations
sufficient to do damage.
i

In addition to the fact that all of the published
I
I
I
I
I
I
I
I
~
I
i
I
I
;
epidemiological studies attempting to show an adverse effect of ETS
on CHD have problems in experimental design, data analysis and
result interpretation, it is also important to emphasize that for
CHD/ETS association to be valid, biologically plausible mechanisms
must be established.
My conclusion, based on a critical evaluation of currently
available scientific data, is that the proposed link between
exposure to ETS and increased risk of CHD is not warranted.
C. Comments on deficiencies and lack of plausibility in
the biological mechanisms proposed for the
cardiovascular effects of ETS
C1. Thrombus formation and platelet activation: Does exposure to
ETS contribute to an altered platelet function?
A thrombus is an abnormal manifestation of normal hemostasis
occurring on the internal surface of blood vessels. Thrombus
formation requires a concerted interaction between the endothelium
and platelets, and appears to proceed in the following manner.
Protection afforded by the vascular endothelium against platelet
aggregation and adhesion (35-37) is lost upon injury of the
endothelium, resulting in a state in which arterial thrombosis is
greatly predisposed. Damaged endothelium enhances platelet
_ .11. .,
aggregation and responsiveness to a number oagonists, and induces
platelet adherence to the subendothelial components, concomitant
with platelet activation and release of a number of mediators,
-
e.g., thromboxane A2, which aggregate new platelets. In parallel,

thrombin is generated on the platelet surface to further stimulate
these reactions. Several conditions known to increase
cardiovascular disease are also associated with increased platelet
aggregation; in contrast, polyunsaturated fatty acids decrease
platelet aggregation and protect against vascular diseases (38-40).
The OSHA IAQ proposal states that "there is evidence that ETS
I
I
I
I
I
I
I
I
I
I
exposure can cause platelets to become more easily activated thus
predisposing the platelets to become involved in forming clots and
atherosclerotic plaques." To support this claim, OSHA cites the
study by Burghuber et al. (41), which involved placing non-smokers
in a confined environment (i8mZ room) and exposing them for an
extended period of time (20 min) to ETS generated by testers
smoking "30 heavy brand" cigarettes. The proposal fails to note
that such artificial experimental settings are unlikely to be
present in real-life situations. Moreover, the 1 mM ADP used to
induce irreversible platelet aggregation is unrealistically high
.... .
and is at least 10-20 times greater than the physiological
concentration of ADP. Another cited study, by Davis et al. (42),
also involved a non-standard platelet aggregation method.
Platelet aggregation is widely recognized to be subject to a
variety of artifacts such as the drawing of blood, presence of
anticoagulant, and centrifugation (43). Platelet reactivity also
displays donor variation, circadian and seasonal changes (44-46),
and extraordinary sensitivity to aggregating agents (47). In
general, there is poor correlation between platelet aggregation and
atherogenic potential of an agent. For example, although saturated
9
I

I
I
I
I
I
I
I
I
I
fatty acid diets are regarded to be atherogenic, they have no
demonstrable effect on platelet function (48).
Active smoking studies do not show a correlation between
smoking and thrombi incidence. In fact, smoking may actually exert
a "protective" effect in certain situations. Haire et al. (49)
investigated the response of fibrinolytic system to active smoking
and observed no difference between control subjects and healthy
.
male smokers challenged with "smoking two cigarette within 15 min".
..... ....
Smoking has no effect on regional cerebral blood flow and on
platelet aggregation in the normal aged volunteers (50) Doll and
Peto found no association between mortality from thromboembolism
and smoking (107). A protective effect of cigarette smoking on
venous thromboembolic disease has been observed after myocardial
infarction and surgery (52, 53). In patients undergoing emergency
laparotomy, cigarette smokers had a significantly lower incidence
of deep venous thrombosis than pipe smokers or nonsmokers (54).
When smokers refrained from smoking and were then challenged with
a cigarette, no difference in collagen-induced platelet
aggregation, thromboxane B2 production by platelets, plasma
. ..... . .. .
thromboglobulin and plasma fibrinopeptide A levels, could be
observed before and after smoking, showing that acute smoking did
not induce a prothrombotic state (55). Cholesterol-fed rabbits did
not show hypersensitivity of platelets to agonists (56).
Thus,-- there is no concrete and consistent evidence for
increased platelet reactivity due to ETS exposure.
C2. Vascular wall injury: Is ETS exposure associated with endothelial
10

cell injury?
The initiation of atherosclerosis requires some form of
1
I
I
I
I
~
~
I
"injury" to be sustained by the arterial endothelium, although the
nature of such °injury" is not well understood; genetic and
environmental factors, singly or interactively, could be involved.
The report of Davis and coworkers was cited in the OHSA IAQ
proposal to support the claim that endothelial cell damage is
,4
induced by ETS exposure (42). The assay used for quantifying
circulating endothelial cells, however, was bascu on the method of
leucoconcentration first described by Hladovec and Rossman (57), in
which only "presumed" endothelial cells were isolated. Davis et al.
did not consider confounding by perceptual reactivity to ETS and
the fact that several vasoactive compounds have been shown to cause
an increase in endothelial cell count (58, 59). ~
C3. Does ETS exposure alter the uptake or the composition of lipids?
According to the OHSA IAQ proposal, ETS "increases the
lipolysis that increases levels of plasma free fatty acids, which
result in enhanced synthesis of LDL". Moreover, ETS was suggested
to have implications "in altering blood lipids". How relevant are
these statements to our current understanding of the role of lipids
in atherosclerosis?
Although excess cholesterol is considered the primary culprit
of atherosclerosis, it has become clear, within the past few years,
that what has traditionally been regarded as the danger of
cholesterol is, more precisely, the danger of high LDL and low HDL.
11
I

When high cholesterol reflects a disproportionally high LDL, then
high total cholesterol is unhealthy. If, on the other hand, total
cholesterol is high because HDL is high, then it is not dangerous.
Accordingly, the newest research places more emphasis on the value
of total cholesterol/HDL: a ratio of less than 3.5 is most
....... ....... .. ..
desirable, one thatlies between 3.5 and 4.5 is considered normal,
.
,
and anything over 7.0 is regarded to be dangerous (60, 61).
When such an empirical relationship is applied to the study of
Moskowitz et al. (62), in which the profile of blood lipor-rotein
.. ...:. . ... ... ...
was investigated in "adolescent children whose parents smoked", no
I
~
~
I
I
I
I
~
I
I
effect of exposure to parental ETS was apparent.
HDL cholesterol levels are known to be affected by diet,
alcohol consumption, and physical activity (63-65). Likewise, the
chemical composition of plasma LDL is modulated by lifestyle
factors (66). In a recent study, Mehrabian et al. (67) showed that
an increase in HDL cholesterol levels, resulting from an over-
expression of the apoprotein AII gene, is accompanied by an
unexpected promotion rather than retardation of aortic fatty streak
development, suggesting that the relationship between HDL and
atherosclerosis is complex and not totally understood.
There is yet another aspect of lipoprotein that deserves some
comment, especially in connection with smoking and ETS exposure,
which mainly relates to the role of LDL as a risk factor for CHD.
It has been suggested that the oxidation of LDL is closely linked
to the process of atherogenesis (68); it has been known for some
time that isolated LDL is highly
susceptible to oxidation and that ~
~
12 ~
~
~
~
~
~

the products of ox.ida.tion are_cytotoxic as well as chemotactic for
,
_ _
monocytes (69, 70). Furthermore, oxidized LDL is capable of
delivering an excess of cholesteryl esters to target cells, via a
receptor-independent and therefore unregulated mechanism.
Accordingly, cigarette smoke, by virtue of its ability to
release free radicals, might be expected to enhance the
susceptibility of LDL to peroxidative modification (71). Contrary
to expectation, however, smoking does not constitute a risk for CHD
in Far East countries with a high prevalence of smoking, as the
average plasma LDL and the LDL/HDL ratio in those populations is
relatively low (72). Recent studies also suggest that native and
oxidized LDL exhibit a complex, agonist-specific effect on platelet
activation (73).
In sum, there is no evidence to show that plasma LDL/HDL are
modulated by ETS in such a way as to exert atherogenic potential.
C4. Is ETS exposure associated with increased proliferation of
smooth muscle cells?
An increase in vascular smooth muscle cell (SMC) proliferation
is thought to play a role in atherosclerosis. While SMC in normal
arteries of adult animals reside in a state of quiescence, they can
be induced to proliferate and ultimately migrate into the intima by
autocrine and paracrine mechanisms, mediated via a variety of
chemical, mechanical, or biologic factors (74-80).
. . ... .
.. ......
.... .
_ _
Two explanations have been offered on the "quiescence-to-
. ........ ........... .:... .... ....., ... ......... ......... ......................
.................... ...........
_.
proliferation" transition of smooth muscle cells. The "response-to-
injury" injury" hypothesis suggests that systemic and local changes in the
13

arterial network result in injury to the.endothelial cell lining
the arterial tree, thereby eliciting a cascade of events to trigger
smooth__muscle cell proliferation (74, 76). A second "monoclonal
1
I
I
I
I
~
~
I
I
smooth muscle cell hypothesis" proposes that the monoclonal
atherosclerotic plaques may, through viral infections or other
insults, be activatad to proliferate uncontrollably.
..... .........
It has been speculated tat the "monoclonal" nature of SMC
will permit them to proliferate when exposed to an insult such as
ETS. In support of such
speculation,
polycyclic aromatic
hydrocarbons, chemical components in ETS, were reported to induce
atherosclerosis in animal studies (86-89). These speculations lack
biological plausibility for the following reasons. First, the
,:..._. ..
animal species used (86-89), the chicken, develops large
atherosclerotic plaques spontaneously by one year of age. Second,
administration of the polycyclic hydrocarbons, as a bolus,
intramuscularly, in animal studies, is not representative of ETS
exposure. Finally, of the many chemicals present in ETS, only a
few, such as carbon monoxide, exist as gases under ambient
conditions and have the potential to reach the endothelial lining
in diluted quantities. Recent studies, however, show that chronic
exposure to moderate levels of carbon monoxide did not accelerate
atherosclerosis in cockerels (86). Other chemicals in ETS
possessing potentially harmful effects, e.g., suspected carcinogens
such as 2-naphthylamine, 4-aminobiphenyl, benzo(a)pyrene, N-
nitrosodimethylamine, acetamine, formaldehyde, are known to have
relatively high vaporization points. Thus, physically, they are
14
I

unable to remain as gases, even at lower ambient temperature, and
I
still less likely, at the higher temperature of the human body.
Thus to imply that risk of exposure to ETS is in part attributed to
such chemicals gaining excess to
chemically implausible.
In conclusion; the existing data do not establish
the endothelial lining is
an
association between ETS exposure and induction of smooth muscle
proliferation.
C5. What is the biological relevance of exposure to ETS on oxygen
supply and cardiac functions?
Among the chemical components of ETS, carbon monoxide and
nicotine have been suggested as most likely to adversely affect
cardiovascular function. Carbon monoxide binds tightly to
hemoglobin and diminishes oxygen transport in the blood stream.
Nicotine acts in the brain and throughout the body, promoting the
release of catecholamines and increasing heart rate and blood
.........
pressure. Although high exposure to these substances might impair
;.
cardiovascular performance, exposure from ETS would be too low for
physiological changes to occur in healthy persons.
A number of publications, notably those of Aronow (89, 90),
were cited in the OHSA IAQ proposal to support the assertion that
ETS exposures leads to an interruption in the coronary circulation,
........ .. ...... . .......... . ....
resulting in ischemia. In the Aronow study, it was suggested that
the lack of oxygen delivery to tissues may result in lactic acid
I accumulation that would irritate the heart and stimulate
spontaneous contraction of cardiac muscle in a.non-coordinated
0
i
I5 M
~
W
.;~
I W
N

I
~
~
I
I
I
I
I
I
I
t
manner, resulting in compromised cardiovascular function. These
studies were largely inconclusive because of deficiencies in study
design and data interpretation. For example, the premature
, .
ventricular contraction data were only recorded in one group after
exercise. Moreover, lactate is primarily produced by exercising
skeletal and not cardiac muscles (due to the unique distribution
and properties of lactate dehydrogenase amongst tissues). Also, the
studies lacked controls for confounding.
The hypothesis that cigarette smoking has an acute effect on
exercise capacity was recently evaluated by subjecting subjects to
treadmill exercise (91). No important acute effects on treadmill
exercise performance could be demonstrated in active cigarette
smokers. Sheps et al. (92, 93) have shown blood that contained as
much as 4% carboxyhemoglobin had no adverse effects on patients
with ischemic heart disease. Also, in patients with frequent
ventricular ectopic activity, exposure to CO producing either 3% or
5% carboxyhemoglobin does not increase arrhythmia frequency of
single or multiple beats during rest or exercise (94). It is
therefore highly implausible that elevation of CO levels resulting
from ETS exposure would show a demonstrable harmful effect.
At the cellular level, the work of Gvozdjakova et al. (95) was
cited by OSHA as evidence for an effect of ETS exposuze on
mitochondrial functions, which conceivably could lead to reduced
energy production and..hence compromised cardiac function. The cited
studies, however, were poorly performed and lacked proper controls.
For example, mitochondrial function was measured inadequately using
16
I

one concentration of glutamate, instead of a number of substrates,
studied over a broad range of physiologically relevant
concentrations.
I
I
I
I
I
r
I
I
In conclusion, there is no solid support for the notion that
....... ......... .... .... .
ETS exposure compromises cardiac functions.
C6. How appropriate is it to extrapolate findings from animal studies
to investigations involving human subjects?
Recently Zhu et al. (97) suggested that the elevated Sudan IV-
stainable lipid streaks in both the aorta and pulmonary arteries of
stainable
New Zealand rabbits fed a high cholesterol diet followed by
exposure to a "low" and "high"..concentr.ation of ETS for an extended
period of time is evidence for ETS-induced endothelial damage and
hence atherosclerosis. Although the use of cholesterol-fed rabbits
is a traditional and easy way of initiating atherosclerosis, the
high plasma cholesterol levels produced in this way are even higher
than in patients with familial hypercholesterolemia. Thus, such a
model is relevant only to a small atherogenesis-prone proportion of
the human population and ..differs considerably from native
atherosclerosis in most humans. Moreover, in the absence of other
supporting evidence, it is not appropriate to interpret measured
lipid streaks as being equivalent to the development of
atherosclerosis. Such fatty streaks and intimal thickening have
been found in most Finish and American children (98), some as young
as three years (regardless of community prevalence of adult artery
..... .... . . ... .. ... . . ...
disease) (99, 100), leading some to question their importance.
Indeed, biliary obstruction, which can result from CNS-triggered

t
~
~
~
I
I
I
I
I
I
I
I
I
I
muscle spasm but bears no relation to atherosclerosis, also
,
promotes lipid deposition in vessel wall.
Finally, the question of whether animal studies have
predictive values in humans must also be addressed. Species
differences are known to exist in susceptibility to carcinogens and
other environmentalagents (101-105). Information such as route of
exposure, bioavailability, and dose response obtained by using
animal models must be properly and carefully evaluated before the
findings can be relevantly extrapolated to humans. These types of
issues, in relation to ETS exposure studies using animals, clearly
have not been adequately addressed.
C7. Confounding
It is clear that loss of functional integrity of-the vascular
endothelium is a primary initiating event in the etiology of-
atherosclerosis.' Endothelial cells interact with blood components
and the abluminal tissues, thus playing an active role in many
aspects of vascular functions.
Nutrition may play an important role in the atherosclerotic
disease process. There is evidence that certain vitamins and
minerals prevent some metabolic and physiological perturbations of
the vascular endothelium (106-112). For example, inadequate intake
of vitamin C could predispose endothelial cells to damage. Vitamin
C is essential for the maintenance of the body's cornective tissue-
the "glue" that holds the cell together. Even though enough of the
vitamin may be present to prevent scurvy, sub-optimal amounts may
lead to weakening of the connective tissue bo
18
I

cells, thus making them more vulnerable to disruption. The
involvement of nutrients as a ma jor confounding factor has not been
systematically addressed in epidemiological and laboratory studies
dealing with the cardiovascular effects of ETS exposure.
.. ....... ....
D. An alternative explanation for the observed effects of
ETS
D 1. Psychoactive response to ETS
The distinct odor of ETS and the likelihood that it could act
as an irritant for some individuals (59) raises the possibility
that the claimed effects of'ETS exposure on endothelium is no more
than a simple psychoactive response which in turn triggers
vasospastic perturbations. Over time, vasospastic episodes produce
vasospasm which initiates endothelial injury and the sequelae of
....... :.::
events culminating in atherosc2erosis A vasospastic theory indeed
has been proposed to explain a myriad of human diseases, including
atherosclerosis, by suggesting that an increased sympathetic
nervous activity could lead to focal spasm resulting in a reduction
..
of oxygen supply (113, 114).
D. Psychoactive factors and pathogenesis of atherosclerosis
Indeed, behavioral and psychosocial factors have been
implicated in the pathogenesis of atherosclerosis for decades.
Animal studies have demonstrated that the sympathetic arousal
invoked by,psychosocial variables, commonly known as "stress", is
accompanied by endothelial dysfunction of the coronary arteries and
aorta, as judged by enhanced immunoglobulin G incorporation and
.
19

I
I
I
I
I
I
I
I
I
I
endothelial cell replication (115). The demonstration by Pettersson
,
et al. (116) that chlora lose- induced endothelial celll injury in
rabbits is effectively blocked by m.etoprolol, a$1-adrenergic
antagonist, further.support the notion that increased sympathetic
~ nervous activity and catecholamines are intimately involved in
aortic endothelial-cell damage and possibly atherogenesis. Sbim,
manifested not necessarily in the typical hard-driving type A
personality, but as anger, frustration, powerlessness, present
risks to general health and to the heart.
The report of a World Health Organization Expert Committee on
the prevention of CHD (117) noted that:
"Several behavioral patterns and psychological and social
variables have been related to CHD risk..... With respect to stress,
or response to stress, the lack of definition and quantitative
measurement is severely limiting..... The Expert Committee noted the
danger that public and professional misconceptions about stress,
whereby.it is assigned a primary role in the genesis of CHD, may
divert attention from the demonstrated needs in prevention."
The potential importance of psychosocial variables in CHD is
further bolstered by the_results of a prospective study by Lehr,
Messinger and Rosenman (118). The authors measured 12 biochemical
and other biological risk factors, and 12 "social" variables
(factual descriptions relating to the social background of the
individuals such as parental country of birth, parent's occupation,
subject's education, residence, etc). Despite the fact that these
,
variables do not begin to encompass the full range of psychological
20
I

factors, perceptions and life events that influence people, the
I
I
I
~
I
I
I
I
social variables were reported to be important predictors of CHD.
In a discriminant analysis comparing CHD cases with CHD-free
controls, a "parental religious difference factor" was the second-
. ...... ... ........
best discriminant, and "father's occupation" and "behavior pattern"
were more discriminating than eight of the biological risk factors.
Of the biological risk factors, only age, systolic pressure,
smoking and serum cholesterol levels contributed in the
discriminant analysis, and these did not account for much c+f the
predictable variance.
The potential causal role of psychological variables or mental
stress in CHD was further supported by Rozanski et al (119) using
CHD patients. The.ir research showed that some mental stressors can
induce elevation in arterial pressure and abnormalities in heart
wall motions in ways comparable to that induced by exercise in CHD
patients. Moreover, the mental-stressor-induced minor ischemia
occurred at lower heart rates than that produced by exercise. In
these studies, four mental stress tasks (simulated public speaking
on a personal subject, doing arithmetic, reading aloud, and the
Stroop color-word task) were compared with the effects of exercise.
Nearly 60% of the patients had heart wall motion abnormalities
(assessed by radionuclide ventriculography) while performing the
mental tasks, with 36% showing a fall in left ventricular ejection
fraction of at least 5% points (reflecting the inability of the
heart to respond flexibly). The public speaking task also produced
ischemic changes as.large as exercise, even though it was not rated
21
I

by the patients as being more tension-producing, anxiety-provoking,
or arousing-challenging than the arithmetic or Stroop tasks. This
study strongly suggests that mental stress can have silent and
I
I
I
I
I
I
I
I
I
I
I
significant effects on the cardiovascular system.
The importance of "stress" as a risk factor for CHD in humans
has been supported ry animal studies. Animal models have shown that
chronic exposure to stress potentiates coronary artery
..
atherogenesis among animals of high social rank, independent of the
concomitant variability in the animals serum lipid concentration.
The sympathetic arousal invoked by social manipulation is
..... ........ .........
accompanied by endothelial dysfunction of the coronary arteries and
aorta, as evidenced by enhanced immunoglobulin G incorporation and
endothelial cell replication (120).
Indeed, certain personality features such as chronic anger
ranks with, or even exceeds cigarette smoking, obesity and a high
fact diet as a powerful risk factor for early death (121).
Personality traits most clearly linked to heart disease and other
health disorders are hostility, suspiciousness, aggressiveness and
a volatile temper. Hostile people often have a more reactive
sympathetic nervous system than others, and their bodies tend to
produce abnormally high levels of catecholamines. These hormones
can stimulate a wide spectrum of effects, raising blood pressure,
quickening the heart beat, and dilating the pupils. over time,
excessive adrenaline and insufficient acetylcholine can lead to a
host of problems, including stiffening of the arteries from
constantly elevated blood pressure and the heart weakens from
22
I

I
I
I
I
I
I
I
I
I
I
I
I
I
k
overexertion. Stress hormones also have been shown to damage the
liver and kidney and to release too'much fat from fat stores, which
could explain why those who are hostile as teen-agers have high
cholesterol levels as adults. In a study based_upon a random
population sampling comprising 1/3 of all men born in Gothenburg
and living in tha city in 1963, Wilhelmsen reported that
psychological stress and low social class are independent risk
factors for coronary heart disease, with an associated relative
risk of 1.6 and 1.3, respectively, as compared to a relative risk
of 2.3 for active smokers in a multivariate analysis involving 7495
subjects followed for 11.8 years. In fact, as far as stroke is
concerned, multivariate analysis showed that psychological stress
(RR=1.7) actually ranked higher than active smoking (RR=1.5) (122).
The influence of emotional states on the frequency of
cardiovascular diseases and fatalities is most vividly illustrated
by a recent publication showing that the perceived threat of
annihilation in connection with the Iraqi missile war produced a
sharp rise in the incidence of acute myocardial infarction and
sudden death in Israeli civilians. Peak incidence closely coincided
with onset of the war (123).
E. Conclusion
The average citizen is exposed daily to both anthropogenic and
natural contaminations from air, water, soils, food, and wastes.
These exposures occur both indoors and outdoors and vary according
to the life-style of the individuals as well as the area in which
23
I

1
I
I
I
I
I
I
I
I
I
I
I
I
they live. While the adverse health effects resulting from the most
dramatic acute,, high level exposures to environmental contaminants
that occur in occupation or emergency situations are easy to
identify clinically, the effects caused by low level, chronic
exposures that occur in ambient environmental settings are much
more difficult to determine. An added complication is that while
there is a tendency to examine the health effects of pollutants
from the perspective of only one environmental media, such
exposures are rarely limited to a single media. If these multi-
media exposures are actually included as part of the process, the
modeling of health effects produced by environmental pollutants can
become overwhelmingly complex.
It has been suggested that prolonged exposure to ETS may
increase the risk of heart disease. Nonetheless, studies focusing
on this issue fall far short of providing conclusive evidence for
a causal association. Potential confounders deserve continued
evaluation as possible bases for spurious positive results in
epidemiologic studies. The multifactorial nature and the diversity
of heart diseases makes it difficult to determine which confounders
are the most important.
In conclusion, the issue of ETS and the claimed link to a host
of human diseases can not be scientifically resolved on the basis
of currently available information. The findings vary in magnitude
of effect and consistency among even the positive studies regarding
the specific heart diseases that might be most affected. Given the
biases and methodological limitations present in each of these
24
I

studies, the significance of the associations is questionable.
Thus, the literature on ETS exposure and heart diseases
remains equivocal.
I
I
I
I
I
I
I
I
I
I
I
. ~
Q
2 5 'CIT
~
~
N
~
N

Figure Legend
Figure i. stages in the development of atherosclerotic plaque. A,
norm..al appearance of the endothelium of an artery. B, endothelial
injury results in the adherence of platelets to the damaged area.
Platelets stimulate proliferation of smooth muscle cells in the
tunica media and intima. C, lipoproteins and cholesterol accumulate
along the endothelium. The atheroma enlarges as the process of
"endothelial injury-SMC proliferation-lipid accumulation" is
repeated. The endothelium is stretched and pushed into the lumen of
the artery, forming an atherosclerotic plaque. D, the endothelium
may rupture, triggering clot (thrombus) formation.
I
I
I
I
I
I
~
0
26 L7D
_ - W
*A
W
I

2057837244
,
6
.9
w
a~ .. ..; ~. ..~ rat w. +r.~ ~ ..~ .r r ~r.. ~..r .. .. .. r~ .rr

R6terences
1. Robbins, S.L., Angell, M., and Kumar, V. (1981) Basic Pathology,
3rd edition, Philadelphia, PA: Saunders, PP289-299.
2. Stehbens, W.E. (1991) J. Clin. Epidemiology 44, 999-1006.
imprecision of the clinical diagnosis of coronary disease in
epidemiological studies and atherogenesis.
,..
3. Kuller, L., Borhani, N., Furberg, C., Gardin, J., Manolio, T.,
O'Leary, D., Psaty, B., and Robbins, J. (1994) Am. J. Epidemiol.
139, 1164-1179. Prevalence of subclinical atherr%-,clerosis and
I
I
I
I
I
I
I
I
I
,
cardiovascular study
r cardiovascular disease and association with risk factors in the
4. Strong, J.P., Solberg, L.A. and Restrapo, C. (1968) Lab.
,
Invest. 18, 527-537. Atherosclerosis in persons with coronary
heart disease.
5. Kupari, M., Hekali, P., Keto, P., Poutanen, V-P, Tikkanen, M.J.,
and Standertskjold-Nordenstam, C.G. (1994) Arterioscler. Throm.
14, 386-394. Relation of aortic stiffness to factors modifying
the risk of atherosclerosis in healthy people.
6. Ross, R., and Glomset, J.A. (1976) N. Engl. J. Med. 295, 369-
372. The pathogenesis of atherosclerosis.
7. Benfante, R.J., Reed, D.M., MacLean, C.J., and Yano, K. (1989)
J. Clin. Epidemiol. 42, 95-104. Risk factors in middle age that
predict early and late onset of coronary heart disease.
8. Wu, C.C.., Chen, S.J., and Yen, M.H. (1992) Clin. and Exptl.
Pharmacol. and Physiol. 19, 833-838. Effects of noise on blood
pressure and vascular reactivities.
27

I
I
I
I
I
I
I
I
I
I
I
I
9. Garrity, T.F., Kotchen, J.M., McKean, H.E., Gurley, D., and
McFadden, M. (1990) Am. J. Public Health 80, 1354-1357. The
association between type A behavior and changes in coronary risk
_ _
factors among young adults.
10.Netterstrom, B., Kristensen, T.S., Damasgaard, M.T., Olsen, 0.,
and Sjol, A. (1991) Br. J. Industrial Med. 48, 684-689. Job
strain and cardiovascular risk factors: a cross sectional study
of employed Danish men and women..
i1.Riemersma, R:A., Wood, D.A., Macintyre, C.C., Elton, R.A., Gey,
K.F., and Oliver, M.F. (1991) Lancet 337, 1-5. Risk of angina
pectoris and plasma concentrations of vitamins A, C, and E and
carotene.
12.Thompson, S.G., Greenberg, G., and Meade, T.W. (1989) Br. Heart
J. 61, 403-409. Risk factors for stroke and myocardial
infarction in women in the United Kingdom as assessed in general
practice: a case-control study.
13.Mancia, G., Groppelli, A., Casadei, R., Omboni, S., Mutti, E.,
and Parati, G. (1990) Clin' and Expt. Hyper-Theory and Practice
A12, 917-929. Cardiovascular effects of smoking.
14.Vogt, T.M., Mullooly, J.P., Ernst, D., Pope, C.R., and Hollis,
J.F. (1992) J. Clin. Epidemiol. 45, 659-666. Social networks as
predictors of ischemic heart disease, cancer stroke and
hypertension: Incidence, survival and mortality.
15.He1mer,*'D.C., Ragland, D.R., and Syme, S.L. (1991) Am. J.
Epidemiol. 133, 112-122. Hostility and coronary artery disease.
16.Ouchi, Y., Tabata, R., Stergiopoulos, K., Sato, F., Hattori, A.,
28
I

~ and Orimo, H. (1990) Arteriosclerosis 10, 732-737. Effect of
~
I
I
dietary magnesium on development of atherosclerosis in
cholesterol-fed rabbits.
17.Beaglehole, R. (1990) Epidemiol. Rev. i2, 1-15. International
trends in coronary heart disease mortality, morbidity, and risk
18.Lassila, R., Seyberth, H.W., Haapanen, A., Schweer, H.,
factors.
Koskenvuo, M., and Laustiola, K.E. (1988) Br. Med. J. 297, 955-
,;
957. Vasoactive and atherogenic effects of cigarette smoking: a
I study of monozygotic twins discordant for smoking.
I 19.Porrini, M., Sinmonetti, P., Testolin, G., Roggi, C., Laddomada,
M.T. (1991) J. Epidemiol. ~ Commun. Health
and Tenconi
M
S
I
I
I
I ,
.
.,
......... .... .... . ..........
45, 148-151. Relation between diet composition and coronary
heart disease risk factors.
20.Kambara, H., Imoto, A., Owada, C., Tamaki, S., Fudo, T., and
Maetani, S. (1992) Japanese Circ. J. 56, 1199-1205. Coronary
risk factors used to predict coronary artery disease by logistic
regression analysis.
21.Eliot, R.S. (1987) Circulation 76, Suppl. 2. Coronary artery
I
I
I , ,_.
heart disease: behavior factors, overview.
22.Baker, R.R., and Proctor, C.J. (1990) Environ. Internat. 16,
231-245. The origin and properties of environmental tobacco
smoke.
23.Reasor,-M.J. (1987) J. Environ. Health 50, 20-24. The
composition and dynamics of environmental tobacco smoke.
I 24.Reasor, M.J. and Will, J.A. (1991) J. Smoking-Related Dis. 2,
~
Gfi
I 29
00
W
I ~
~
~

111-127. Assessing exposure to environmental tobacco smoke: Is
I
I
I
I
I
I
I
I
I
I
it valid to extrapolate from active smoking?
25.Gills, C., Hole, D., Hawthorne, V. and Boyle, P. (1984) Eur. J.
-
Resp. Dis. 65 (suppl. 133), 121-126. The effect of environmental
tobacco smoke in two urban communities in the west of Scotland.
.
26.Hole, D.J., Gillis, C.R., Chopra, C. and Hawthorne, V.M. (1989)
.................... ...... ... . ...... .. ........ . .
Br. Med. J. 299, 423-427. Passive smoking and cardiorespiratory
,
health in a general population in the West of Scotland.
27.Svendsen, X., Kuller, L., Martin, M. and Ockene, J. (1987) Am.
J. Epidemiology 126, 783-795. Effects of passive smoking in the
Multiple Risk Factor Intervention Trial.
. . . . .......
28.Helsing, K., Sandler, D., Comstock, G. and Chee, E. (1988) Am.
J. Epidemiology 127, 915-922. Heart disease mortality in
nonsmokers living with smokers.
29.Hirayama, T. (1984) in Mizell, M. and Correa, P. (eds.): Lung
Cancer: Causes and Prevention, pp175..-195. Lung cancer in Japan:
Effects of nutrition and passive smoking, Verlag Chemie
International, New York.
30.Garland, C., Barrett-Connor, E., Suarez, L., Criqui, M. and
Wingard, D. (1985) Am. J. Epidemiology 121, 645-650. Effects of
passive smoking on ischemic heart disease mortality of
nonsmokers.
31.Humble, C., Croft, J., Gerber, A., Casper, M., Hames, C. and
Tyroler, H..(1990) Am. J. Public Health 80, 599-601. Passive
smoking and twenty year cardiovascular disease mortality among
nonsmoking wives in Evans County.
30
I

2057837Z49
1
.r m mm m... =..r m m r mmr.. ... m ..rN = ...

I
~
~
~
~
I
I
I
I
I
I
32.Lee, P., Chamberlain, J. and Alderson, M. (1986) Br. J. Cancer
,
,
54, 97-105. Relationship of passive smoking to risk of lung
cancer and other smoking-associated diseases.
33.He, Y., Li, L.X. and Fong, C.C. (1989) Chinese J. of Preventive
Medicine 23, 19-22. Passive smoking in females and coronary
heart disease. ,
34.Dobson,' A.J., Alexander, H.M., Heller, R.F. and Lloyd, D.M.
(1991) The Medical J. of Australia 154, 793-797. Passive smoking
and the risk of heart attack or coronary death.
35.Cohen, R.A., Shepherd, J.T., and Vanhoutte, P.M. (1983) Science
221, 273-274. Inhibitory role of the endothelium in the response
of isolated coronary arteries to platelets.
36.Houston, D.S., Shepherd, J.T., and Vanhoutte, P.M. (1985) Am. J.
Physiol. 248, H389-H395. Adenine nucleotides, serotonin, and
endothelium-dependent relaxation to platelets.
37.Azuma, H., Ishikawa, M., Sekizaki, S. (1986) Br. J. Pharmacol.
,. . _
88, 441-445. Endothelium-dependent inhibition of platelet
aggregation.
38.Knapp, H.R., Reilly, I.A., Allessandrini, P., and Fitzgerald,
G.A. (1986) N. Engl. J. Med. 314, 937-942. In vivo indexes of
platelet and vascular function during fish-oil administration in
patients with atherosclerosis.
39.Von Schacky, C., and Weber, P.C. (1989) J. Clin. Invest. 76,
2446-2450. Metabolism and effects on platelet function of the
purified eicosapentaenoic and decosahexaenoic acids in humans.
40.Kristensen, D.S., Schmidt, E.B., and Dryerberg, J. (1989) J. ~
. . . . . ... . .. ~I
`+1
31 ~
~
~
~
®
I

I
~
I
I
I
I
I
I
I
I
Intern. Med. 225 (suppi 1), 141-150. Dietary supplementation
with n-3 polyunsaturated fatty acids and human platelet
function: A review with particular emphasis on implications for
cardiovascular disease.
. ... ...... ... ... . . ...... . . . .
41.Burghuber, O.C., Punzengruber, C., Sinzinger, H., Haber, P., and
Silberuer, K. (1986) Chest 90, 34-38. Platelet sensitivity to
prostacyclin in smokers and non-smokers.
,
42.Davis, J.W., Sheldon, L., Watanabe, I., and Arnold, J. (1989)
Arch. Int. Med. 149, 386-389. Passive smoking affects
endothelium and platelets.
43.Kutti, J. (1990) Smoking, platelet reactivity and fibrinogen.
In Diana, J.N. (ed.): Tobacco smoking and atherosclerosis.
Pathogenesis and cellular mechanisms. Plenum Publishing Corp.,
NY.
44.DeMet, E.M., Bell, K.M., Reist, C., Gerner, R.H., and Chicz- -
DeMet, A. (1990) Psychiatry Res. 34, 315-329. Seasonal changes
in cyanoimipramine specific platelet 3H-imipramine binding in
depression.
45.Ellis, P.M., Beeston, R., Cooke, R.R., and Melisop, G. (1991)
Pharmacopsychiatry 24, 76-80. Circadian variation in platelet
imipramine binding during the day in healthy subjects.
46.Silver, W.P., Keller, M.P., Teel, R., and Silver, D. (1993) J.
Vasc. Surg. 17, 726-733. Effects of donor characteristics and
platelet in vitro time and temperature on platelet aggregometry.
47.Thomas, J.S., McConnell, M.F., Bell, T.G., and Padgett, G.A.
(1992) J. of Hypertension 10, 1493-1498. Platelet aggregation
32

and dense granule secretion in a colony of dogs with
spontaneous hypertension.
48.Schick, P.K., Wojenski, C.M., and Walker, J. (1993)
Arteriosclerosis & Thrombosis 13, 84-89. The effects of oliver
oil, hydrogenated palm oil, and omega-3 fatty acid-enriched
diets on megakaryotes and platelets.
49.Haire, W.D., Goldsmith, J.C., and Rasmussen, J. (1988) Am. J.
I
I
I Hematology 31, 36-40. Abnormal fibrinolysis in healthy male
cigarette smokers: Role of plasminogen activator inhibitors.
50.Yamashita, K., Kobayashi, S., Yamaguchi, S., Kitani, M., and
Tsunematsu, T. (1988) Gerontology 34, 199-204. Effect of smoking
on regional cerebral blood flow in the normal aged volunteers.
51.Doll, R., and Peto, R. (1976) Br. Med. J. 2, 1525-1536.
Mortality in relation to smoking: 20 years' observations on male
British doctors...
5.2..Handley, A.I., and Teather, D. (1974) Br. Med. J. 3, 230-231.
I
I Influence of smoking on deep vein thrombus after myocardial
infarction.
53.Barbash, G.I., White, H.D., Modan, M. et al. (1993)
I Circulation 87, 53-58. significance of smoking on patients
receiving thrombolytic therapy for acute myocardial infarction.
..... .... ......... . ..... ... ... .. ... . ..... ... . . .... . .
I Experience gleaned from the international tissue plasminogen
activator/streptokinase mortality trial.
I 54.Pollack; A.V., and Evans, M. (1978) Br. Med. J. 3, 637-639. --
. ~
I Cigarette smoking and postoperative deep vein thrombosis. -~
55.Vicari, A.M., Margonato, A., Macagni, A. et al. (1988) Clin ~
. G0
~
I 33 -j
I
I ?v

Cardiology 11, 538-540. Effects of acute smoking on the
hemostatic system in humans.
56.Gross; P.L., Rand, M.L., Barrow, D.V.and Packham, M.A. (1991)
Atherosclerosis 88, 77-86. Platelet sensitivity in cholesterol-
fed rabbits: enhancement of thromboxane A,-dependent and
thrombin-induced, thromboxane A2-independent platelet responses.
57.Hladovec, J., and Rossman, P. (1973) Thrombosis Res. 3, 665-
674. Circulating endothelial cells isolated together with
platelets and the experimental modification of their counts in
rats.
I
I
I
I
I
~
I
I
58.Hladolvec, J. (1978) Physiologia bohemoslov 27, 140-144.
Circulating endothelial cells as a sign of vessel wall lesions.
59.Urch, R.B., Silverman, F., Corey, P., Shephard, R.J, Cole, P.,
and Goldsmith, L.J. (1988) Envir. Res. 47, 34-47. Does
suggestibility modify acute reactions to passive cigarette smoke
exposure?
60.Linn, S., Fuiwood, R., Carroll, M., Brook, J.G., Johnson, C.,
Kaisbeek, W.D., and Rifkind, B.M. (1991) Am. J. Public Health
81, 1038-1043. Serum total cholesterol:HDL cholesterol ratios in
US white and black adults by selected demographic and
socioeconomic variables (HANES II).
61.Grundy, S.M., Greenland, P., Herd, A., Huebsch, J.A., Jones,
R.J., Mitchell, J.H., and Schiant, R.C. (1987) Circulation 75,
1339A-1362A. Cardiovascular and risk factor evaluation of
healthy American adults.
62.Moskowitz, W.P., Mosteller, M., Schieken, R.M., Bossano, R.,
34
i

Hewitt, J.K., Bodurtha, J.N., and Segrest, J.P. (1990)
Circulation 81, 586-592..Lipoprote}n and oxygen transport
alterations in passive smoking preadolescent children. The MCV
twin study.
63.Wilson, P.W., Garrison, R.J., Abbott, R.D., and Castelli, W.P.
(1988) Arteriosclerosis 3, 273-278. Factors associated with
lipoprotein cholesterol levels.
64.Williams, P.T., Krauss, R.M., Wood, P.D., Albers, J.J., Dreon,
D., and Ellsworth, N. (1985) Metabolism 34, 524-528. Association
of diet and alcohol intake with high-density lipoprotein
subclasses.
65.Manttari, M., Koskinen, P., Manninen, V., Tenkanen, L., and
Huttunen, J.K. (1991) Atherosclerosis 87, 1-8. Lifestyle
determinants of HDLZ- and HDLs-cholesterol levels in a
>.
,
hypercholesterolemic male population. u
66.Houmard, J.A., Bruno, N.J., Bruner, R.K., McCammon, M.R.,
Israel, R.G., and Barakat, H.A. (1994) Arterioscier. Throm. 14,
325-330: Effect of exercise training on the chemical composition
of plasma low density lipoproteins.
67.Mehrabian, M., Qiao, J.H., Hyman, R., Ruddle, D., Laughton, C.,
and Lusis, A. (1993) Arteriosclerosis & Thrombosis 13, 1-10.
Influence of the apoA-II gene locus on HDL levels and fatty
streak development in mice.
68.Steinberg, D., and Witztum, J.L. (1990) J. Am. Med. Assoc. 264,
3047-3052. Lipoproteins and
atherogenesis. Current concepts.
69.Cathcart, M.K., Morel, D.W., and Chisolm,
35
G.M., III (1985) J.

Leuk. Biol. 38, 341-350. Monocytes and neutrophils oxidize low
I
~
~
~
t
I
I
I
I
I
I
~
1
I
I
density lipoprotein making it cytotoxic.
70.Berliner, J.A., Territo, M.C., Sevanian, A., Ramin, S., Kim,
J.A., Bamshad, B., Esterson, M., and Fogelman, A.M. (1990) J.
Clin. Invest. 85, 1260-1266. Minimally modified low density
lipoprotein stimulates monocyte endothelial interactions.
71.Harats, D., Ben-Naim, M., Dabach, Y., Y., Hollander, G., Stein,
0., and Stein, Y. (1989) Atherosclerosis 79, 245-252. Cigarette
smoking renders LDL susceptible to peroxidative modification and
enhanced metabolism by macrophages.
72.Stehle, G., Hinohara, S., Gross, K., Tamachi, H., Kanemoto, N.,
Fehringer, M., Takahashi, T., Goto, Y., and Schettler, G. (1988)
Influence of alcohol consumption, smoking and exercise habits on
blood lipoprotein concentrations in 9256 healthy Japanese
adults. In Endemic Diseases and risk factors for atherosclerosis
in the Far East. Schettler G. ed. pp13-25. Springer Verlag,
Berlin_and Heidelberg.
73.Naseem, K.M., Goodall, A.H., and Bruckdorfer, K.R. (1993)
Biochem. Soc. Transac. 21, 140S. The effects of native and
oxidized LDL on platelet activation.
74.Sachinidis, A., Ko, Y., Wieczorek, A., Weisser, B., Locher, R.,
Vetter, W., and Vetter, H. (1993) Biochem. Biophys. Res. Commun.
192, 794-799. Lipoproteins induce expression of the early growth
response gene-1 in vascular smooth muscle cells from rat.
75.Miller, G.J., and Miller, N.E. (1975) Lancet i, 16-19. Plasma-
high-density-lipoprotein concentration and development of ~
. O
36 ~
~
~
Cj
~
~
~

I
I
I
I
I
I
I
I
I
I
I
I
ischemic heart-disease.
76.Ross, R. (1986) N. Engl. J. Med. 314, 488-500. The pathogenesis
of atherosclerosis:
An update.
.
77.Fox, P.L., and DiCorleto, P.E. (1984) J. Cell. Physiol. 121,
298-308. Regulation of production of a platelet-derived growth
;
factor-like protein by cultured bovine aortic endothelial cells.
78.Nilsson, J. (1986) Atherosclerosis 62, 185-199. Growth factors
and the pathogenesis of atherosclerosis.
.... 11 ..... . . ...... . ........ ...... ... ....... . . ....... . .
79.Pomerantz, K.B., and Hajjar, D.P. (1989) Arteriosclerosis 9,
413-429. Eicosanoids in regulation of arterial smooth muscle
cell phenotype, proliferative capacity, and cholesterol
metabolism.
..
80.Yutani, C., and Takaichi, S. (1991) Japanese Circ. J. 55, 1003-
1009. The role of vascular smooth muscle cells in atherogenesis:
Phenotype modulation of the medial smooth muscle cells in the
aortic bifurcation.
81.Benditt, E.P., and Benditt, J.M. (1973) Proc. Natl. Acad. Sci.
USA 70, 1753-1756. Evidence for a monoclonal origin of human
atherosclerotic plaques.
82.Albert, R.E., Vanderlaan, M., Burns, F.J., and Nishizumi, M.
(1977) Canc. Res. 37, 2232-2235. Effect of carcinogens on
chicken atherosclerosis.
83.Penn, A., Batastini, G., Soloman, J., Burns, F., and Albert, R.
(1981)..Canc. Res. 41, 588-592. Dose-dependent size increases of
aortic lesions following chronic exposure to 7, 12-
dimethylbenz(a)anthracene.
37
I

I
I
I
I
I
I
I
I
84.Majesky, M.W., Yang, H.L., Benditt, E.P., and Juchau, M.R.
(1983) Carcinogenesis 4, 647-652. Carcinogenesis and
atherogenesis: differences in monooxygenase inducibility and
bioactivation of benzta)pyrene in aortic and hepatic tissues of
atherosclerosis-susceptible versus resistant pigeons.
85.Revis, N.W., Bull, R., Laurie, D., and Schiller, C.A. (1984)
Toxicology 32, 215-227. The effectiveness of chemical
carcinogens to induce atherosclerosis in the white corneau
pigeon.
86.Penn, A., Currie, J., and Snyder, C. (1993) Eur. J. Pharmacol.
228, 155-164. Inhalation of carbon monoxide does not accelerate
atherosclerosis in cockerels.
87.Glomset, J.A. (1968) J. Lipid Res. 9, 155-167. The plasma
lecithin-cholesterol acyltransferase reaction.
88.Bjorkerud, S., and Bjorkerud, B. (1994) Arterioscler. Throm. 14,
288-298. Lipoproteins are major and primary mitogens and growth
promoters for human arterial smooth muscle cells and lung
fibroblasts in vitro.
89.Aronow, W.S. (1978) New Engl. J. Med. 299, 21-24. The effect of
.. ..... .. . . ... ... ............
passive smoking on angina pectoris.
.........
90.Aronow, W.S~. (1981) Am. Heart J. 101, 154-157. Aggravation of
angina pectoris by two percent carboxyhemoglobin.
91.Waller, P.C., Solomon, S.A., and Ramsay, L.E. (1989) Anqiology
. ..........
40, 164.-169: The acute effects of cigarette smoking on treadmill
exercise distances in patients with stable intermittent
claudication.
38
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
92.Sheps, D.S., Adams, K.F., and Bromberg, P.A. (1987) Arch. Envir.
Health 42, 108-116. Lack of effect of low levels of
carboxyhemoglobin on cardiovascular functions in patients with
ischemic heart disease.
93.Sheps, D.S., Herbst, M.C., Hinderliter, A.L., Adams, K.F.,
Ekelund, L.G., O,'Neil, J.J., Goldstein, G.M.,
Bromberg, P.A.,
Ballenger, M., and Davis, S.M. (1991) Res. Rep. Health Eff.
Inst. 1-46. Effects of 4 percent and 6 percent carboxyhemoglobin
on arrhythmia production in patients with coronary artery
disease.
94.Dahms, T.E., Younia, L.T., Wiens, R.D., Zarnegar, S., Byers,
S.L., and Chaitman, B.R. (1993) J. Am. Coil. Cardiol. 21, 442-
450. Effects of carbon monoxide exposure in patients with
documenting cardiac arrhythmias.
95.Gvozdjakova, A., Bada, V., Sany, L., Kucharska, J., Kruty, F.,
Bozek, P., Trstanksy, L., and Gvozdjak, J. (1984) Cardiovasc.
Res. 18, 229-232. Smoke cardiomyopathy: Disturbance of oxidative
process in myocardial mitochondria.
98.Hirvonen, J., Yla-Herttuala, S., Laaksonen, H. et al. (1985)
Acta Pediat. Scand. 318 (suppi.), 221-224. Coronary intimal
thickening and lipids in Finjnish children who died suddenly.
99.Strong, J.P., and McGill, H.C., Jr. ( 1969) Atherosclerosis Res.
9, 251-265. The pediatric aspects of coronary atherosclerosis.
100.Stary;- H.C. (1989) Arteriosclerosis 9(suppl. 1), 119-132.
Evolution and progression of atherosclerotic lesions in
coronary arteries of children and young adults.
39
I

I
I
I
I
I
I
I
I
I
I
101.Peterson, R.E., Theobald, H.M., and Kimmel, G.L. (1993) Crit.
Rev. Toxicol. 23, 283-335. Developmental and reproductive
toxicity of dioxins and related compounds: cross-species
comparisons.
102.Sweet, C.S., and Nelson, E.B. (1993) J. Hypertens. Suppl. 11,
S63-67. How well have animal studies with losartam predicted
responses in humans?
103.Axberg, I. (1988) Scand. J. Immunol. 28, 697-704. Increased
susceptibility of periodate-treated tumor cells to human but
not to mouse or ret natural killer cells.
104.Schwartz, R.S., Edwards, W.D., Bailey, X.R., Camrud, A.R.,
Jorgenson, M.A., and Holmes, D.R., Jr (1994) Arterioscler.
Throm. 14, 395-400. Differential neointimal response to
......
coronary artery injury in pigs and dogs.
105.D'Amato, R., Slaga, T.J., Farland, W.H., and Henry, C. (1992)
Prog. Clin. Biol. Res. 374. Relevance of animal studies to the
evaluation of human cancer risk.
106.Hennig, B., Boissonneault, G.A., and Wang, Y. (1989) Int. J.
Vitam. Nutr. Res. 59, 273-279. Protective effects of vitamin E
in age-related endothelial cell injury.
i07.Hiebert, L.M., and Liu, J.M. (1990) Atherosclerosis 83, 47-51.
Heparin protects cultured arterial endothelial cells from
damage by toxic oxygen metabolites.
108.Jonas,. E., Dwenger, A., and Hager, A. (1993) J. Biolumin.
Chemilumin. 8, 15-20. In vitro effects of ascorbic acid on
neutrophil-endothelial cell interaction.
40
I

I
~
I
I
~
~
~
I
I
I
I
I
I
109.Dickens, B.F., Weglick, W.B., Li, Y.S., and Mak, I.T. (1992)
FEBS Lett. 311, 187-191. Magnesium deficiency in vitro enhances
free radical-induced intracellular oxidation and cytotoxicity
in endothelial cells.
110.Weinberg, J.M., Varani, J., Johnson, K.J., Roeser, N.F., Dame,
M.K., Davis, J.A., and Venkatchalam, M.A. (1992) Am. J. Pathol.
140, 457-471. Protection of human umbilical vein endothelial
cells by glycine and structurally similar amino acids against
calcium and hydrogen peroxide-induced lethal cell injury.
111.Bronk, S.F., and Gores, G.J. (1991) Hepatology 14, 150-157.
Acidosis protects against lethal oxidative injury of liver
sinusoidal endothelial cells.
112.Knekt, P., Reunanen, A., Jarvinen, R., Seppanen, R.,
Heliovaara, M., and Aromaa, A. (1994) Am. J. Epidemiol. 139,
1180-1189. Antioxidant vitamin intake and coronary mortality in
a longitudinal population study.
,
113.Boyd, G.W. (1978.) Med. Hypoth. 4, 420-431. Stress and disease:
The missing link. A vasospastic theory II. The nature of
degenerating arterial disease.
114.Hellstrom, H.R. (1990) Med. Hypoth. 33, 31-41. The spasm of
resistance vessel concept of ischemic heart disease and other
ischemic diseases.
115.Strawn, W.B., Bondjiers, G., Kaplan, J.R., Manuck, S.B.,
Schwenkee, D.C., Hansson, G.K., Shively, C.A., and Clarkson,
T.B. (1991) Circ. Res. 68, 1270-1279. Endothelial dysfunction
in response to psychosocial stress in monkeys.
41
I

I
I
I
I
I
I
I
I
I
I
I
I
I
116.Pettersson, K., Bejne, B., Bjork, H., Strawn, W.B., and
Bondjiers, G. (1990) Circ. Res. 67, 1027-1034. Experimental
sympathetic activation causes endothelial injury in the rabbit
-;.
thoracic aorta via 01-adrenoreceptor activation.
117.World Health Organization (1982). Prevention of Coronary Heart
Disease:Report of a WHO Expert Committee, WHO Technical report
... ..... . . .. ....
series 678, WHO, Geneva.
118.Lehr, I., Messinger, H.B. and Rosenman, R.H. (1973) A
sociobiological approach to the study of coronary heart
disease. J. Chronic Disease 26, 13-30.
119.Rozanski, A., Bairey, C.N., Krantz, D.S., Friedman, M.D.,
Resser, K.J., Morell, M., Hilton-Chalfen, S., Hestrin, L.,
Bietendorf, J. and Berman, D.S. (1988) Mental stress and the
induction of silent myocardial ischemia in patients with
coronary artery disease. New England J. of Medicine 318, 1005=
1011.
120.Strawn, W.B., Bondjiers, G., Kaplan, J.R., Manuck, S.B.,
Schwenkee, D.C., Hansson, G.K., Shively, C.A. and Clarkson,
T.B. (1991) Circulation Research 68, 1270-1279. Endothelial
dysfunction in response to psychosocial stress in monkeys.
..
121.Williams, R.B., Barefoot, J.C. and Haney, T.L. (1988) Psychom.
. ...... . ....... ......... ........ ......... ......... .......... ....... .. ... .. . ...
........
Med. 50, 139-152. Type A behavior and angiographically
documented coronary atherosclerosis in a sample of 2,289
patients.
122.Wilhelmsen, L. (1990) Clin. and Exper. Hyper.- Theory and
Practice, A12, 845-863. Synergistic Effects of Risk Factors
42
I

I
I
I
I
I
I
I
I
I
123.Meisel, S.R., Kutz, I., Dayan, K.I., Pauzner, H., Chetboun, I.,
Arbel, Y. and David, D. (1991) Lancet 338, 660-661. Effect of
...
Iraqi missile,way on incidence of acute myocardial infarction
and sudden death in Israeli civilians.
43
